Efficacy and Safety of Rivaroxaban Versus Low Molecular Weight Heparin for Treating Venous Thromboembolism in Cancer Patients: A Systematic Review and Meta-Analysis

被引：0
|
作者：
Shrestha, Abhigan
Mainali, Nischal
Shrestha, Sajina
Jaiswal, Vikash
Rajak, Kripa
Edara, Ravi Sankar Reddy
Anil, K. C.
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4143604
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4143604
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis
    Zhou, Hong
    Chen, Ting-Ting
    Ye, Ling-ling
    Ma, Jun-Jie
    Zhang, Jin-Hua
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2024, 22 (01)
  • [32] Efficacy and safety of direct oral anticoagulants versus low-molecular-weight heparin for thromboprophylaxis after cancer surgery: a systematic review and meta-analysis
    Hong Zhou
    Ting-Ting Chen
    Ling-ling Ye
    Jun-Jie Ma
    Jin-Hua Zhang
    World Journal of Surgical Oncology, 22
  • [33] The efficacy and safety of low-molecular-weight heparin thromboprophylaxis in critically ill adult patients: a systematic review and meta-analysis
    Ylonen, A.
    Kuitunen, A.
    Vaara, S.
    Pettila, V
    Huhtala, H.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 372 - 372
  • [34] TREATMENT OF CANCER ASSOCIATED VENOUS THROMBOEMBOLISM WITH APIXABAN COMPARED TO LOW MOLECULAR WEIGHT HEPARIN: A META-ANALYSIS
    Rahman, Hammad
    Khan, Muhammad Shahzeb
    Hammad, Tehseen
    Sharma, Saurabh
    Kaluski, Edo
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 2069 - 2069
  • [35] Outpatient therapy with low molecular weight heparin for treatment of venous thromboembolism: A systematic review of efficacy, safety, and costs.
    Segal, JB
    Bolger, DT
    Jenckes, MW
    Tamariz, LJ
    Streiff, MB
    Eng, J
    Krishnan, JA
    Bass, EB
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2003, 18 : 166 - 166
  • [36] Meta-Analysis Comparing Direct Oral Anticoagulants to Low Molecular Weight Heparin for Treatment of Venous Thromboembolism in Patients With Cancer
    Bhatia, Kirtipal
    Uberoi, Guneesh
    Bajaj, Navkaranbir S.
    Jain, Vardhmaan
    Arora, Sameer
    Tafur, Alfonso
    Bangalore, Sripal
    Olin, Jeffrey W.
    Piazza, Gregory
    Goldhaber, Samuel Z.
    Vaduganathan, Muthiah
    Qamar, Arman
    AMERICAN JOURNAL OF CARDIOLOGY, 2020, 133 : 175 - 178
  • [37] Clinical Efficacy and Safety of Novel Anticoagulants for the Management of Venous Thromboembolism in Patients with Cancer: A Systematic Review and Meta-Analysis
    Lee, Mei-Chuan
    Wu, Jheng-Yan
    Yu, Tsung
    Liao, Chia-Te
    Chang, Wei-Ting
    Toh, Han Siong
    Hung, Kuo-Chuan
    Su, Hui-Chen
    CARDIOVASCULAR DRUGS AND THERAPY, 2024,
  • [38] Safety of Direct Oral Anticoagulants as Compared to Low Molecular Weight Heparin in Treating Venous Thromboembolism in Patients with Primary Brain Tumors and Brain Metastases - A Review of Literature and Meta-analysis
    Santiago, Raphael Bastianon
    Shah, Nirja
    Ali, Asad
    Ranjan, Surabhi
    NEUROLOGY, 2023, 100 (17)
  • [39] Safety of Low Molecular Weight Heparin Compared to Unfractionated Heparin in Hemodialysis: A Systematic Review and Meta-analysis
    Harrak, Hind
    Rene, Emilie
    Elftouh, Naoual
    Lafrance, Jean-Philippe
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2015, 24 : 311 - 312
  • [40] An analysis of the safety and efficacy of rivaroxaban (Riv) and low molecular weight heparin (LMWH) in gastrointestinal cancer-associated venous thromboembolism (GICA-VTE).
    Boiles, Alejandro Recio
    Veeravelli, Sumana
    Vondrak, Jessi
    Babiker, Hani M.
    Scott, Aaron James
    McBride, Ali
    Elquza, Emad
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (04)
12345